Literature DB >> 12724019

Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.

T Kazerooni1, M Dehghan-Kooshkghazi.   

Abstract

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine diseases in women. This syndrome is characterized by hyperandrogenism, chronic anovulation, infertility and obesity. The association between PCOS-related hyperandrogenemia and insulin resistance is well documented in the literature. Insulin resistance and the resulting raised plasma levels of insulin are reported to be responsible for the high androgen concentration observed in patients with PCOS. In this prospective study, blood samples for levels of testosterone (T), dehydroepiandrosterone sulfate (DHEAS), luteinizing hormone (LH), follicle-stimulating hormone (FSH), LH/FSH, prolactin and fasting blood sugar (FBS) before starting metformin administration were obtained randomly from 40 women who were apparently obese, had PCOS and had been referred to a university hospital. Metformin was then given at a dose of 500 mg three times a day for 8 weeks, after which time the pretreatment study was repeated. Clinical symptoms of PCOS, including acne and hirsutism score and body mass index (BMI), were assessed before and after the treatment cycle. Metformin therapy resulted in a significant decrease in total testosterone levels and FBS. There was also a significant decline in BMI, length of the menstrual cycle, acne and hirsutism score. There were no significant changes in the levels of DHEAS, prolactin, FSH or LH, or in LH/FSH. The effect of metformin on subjects with elevated DHEAS levels was different to that on individuals with normal DHEAS levels. In the latter group there were only significant improvements in the length of the menstrual cycle, BMI and testosterone and DHEAS levels. It is concluded that metformin therapy in subjects with PCOS results in a decrease in fasting blood sugar and testosterone levels, and leads to a significant improvement in the clinical manifestation of hyperandrogenism. These responses also related to the level of adrenal function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724019

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  9 in total

1.  Profiling and hormonal therapy for acne in women.

Authors:  Sangita Ghosh; Soumik Chaudhuri; Vijay Kumar Jain; Kamal Aggarwal
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

2.  Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder.

Authors:  Christine Brady; Shaymaa S Mousa; Shaker A Mousa
Journal:  Drug Healthc Patient Saf       Date:  2009-02-03

3.  Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia.

Authors:  Azam Ghaneei; Akram Jowkar; Mohammad Reza Hasani Ghavam; Mohammad Ebrahim Ghaneei
Journal:  Iran J Reprod Med       Date:  2015-02

4.  Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial.

Authors:  Sedigheh Amooee; Mohammad Ebrahim Parsanezhad; Maryam Ravanbod Shirazi; Saeed Alborzi; Alamtaj Samsami
Journal:  Iran J Reprod Med       Date:  2013-08

5.  Difference between Primary and Secondary Infertility in Morocco: Frequencies and Associated Factors.

Authors:  Abdelhafid Benksim; Noureddine Elkhoudri; Rachid Ait Addi; Abdellatif Baali; Mohamed Cherkaoui
Journal:  Int J Fertil Steril       Date:  2018-03-18

6.  Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.

Authors:  Romina Fornes; Johanna Simin; Minh Hanh Nguyen; Gonzalo Cruz; Nicolás Crisosto; Maartje van der Schaaf; Lars Engstrand; Nele Brusselaers
Journal:  Reprod Biol Endocrinol       Date:  2022-02-07       Impact factor: 5.211

Review 7.  Role of Metformin in the Management of Polycystic Ovarian Syndrome-Associated Acne: A Systematic Review.

Authors:  Humaira Shamim; Marie Jean; Muaaz Umair; Pratyusha Muddaloor; Michelle Farinango; Akhil Ansary; Amulya Dakka; Zahra Nazir; Chantelle T White; Ahmad B Habbal; Lubna Mohammed
Journal:  Cureus       Date:  2022-08-27

8.  Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.

Authors:  Hsuan Yen; Yu-Tung Chang; Fui-Jun Yee; Yu-Chen Huang
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

9.  Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome.

Authors:  Yazed Sulaiman Al-Ruthia; Hazem Al-Mandeel; Hisham AlSanawi; Wael Mansy; Reem AlGasem; Lama AlMutairi
Journal:  Saudi Pharm J       Date:  2016-12-23       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.